Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Remdesivir (GS-5734) ist eine neue Art von analogem antiviralem Nukleosid-Arzneimittel, das von Gileadscience entwickelt wurde. Es ist ein RNA-abhängiger RNA-Polymerase (RDRP) -Hemmer. Es übt eine antivirale Wirkung aus, indem es die Synthese von viraler Nukleinsäure hemmt.
Produktgruppe : API-Zwischenprodukte > Remdesivir-Zwischenprodukt
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.